Hillstream BioPharma, Inc. (HILS)
NASDAQ: HILS · IEX Real-Time Price · USD
0.600
+0.061 (11.23%)
At close:
Jan 27, 2023, 4:00 PM
0.629
+0.029 (4.90%)
After-hours:
Jan 27, 2023, 7:16 PM EST
Total Valuation
HILS has a market cap or net worth of $6.92 million. The enterprise value is -$678,727.
Market Cap | 6.92M |
Enterprise Value | -678,727 |
Important Dates
The next earnings date is Monday, February 13, 2023, before market open.
Estimated Earnings Date | Feb 13, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
HILS has 11.53 million shares outstanding. The number of shares has increased by 81.40% in one year.
Shares Outstanding | 11.53M |
Shares Change (YoY) | +81.40% |
Shares Change (QoQ) | -0.35% |
Owned by Insiders (%) | 55.50% |
Owned by Institutions (%) | 6.28% |
Float | 3.89M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.97 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.93
Current Ratio | 10.93 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -78.00%.
Return on Equity (ROE) | -78.00% |
Return on Assets (ROA) | -57.50% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.25M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.33% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -84.33% |
50-Day Moving Average | 0.44 |
200-Day Moving Average | 0.82 |
Average Volume (30 Days) | 307,552 |
Short Selling Information
The latest short interest is 23,989, so 0.21% of the outstanding shares have been sold short.
Short Interest | 23,989 |
Short Previous Month | 10,014 |
Short % of Shares Out | 0.21% |
Short % of Float | 0.62% |
Short Ratio (days to cover) | 0.19 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -5.22M |
Pretax Income | -4.25M |
Net Income | -4.25M |
EBITDA | -2.40M |
EBIT | -2.40M |
Earnings Per Share (EPS) | -$0.22 |
Balance Sheet
Cash & Cash Equivalents | 7.60M |
Total Debt | n/a |
Net Cash | 7.60M |
Net Cash Per Share | $0.66 |
Equity / Book Value | 7.12M |
Book Value Per Share | 0.62 |
Working Capital | 7.12M |
Cash Flow
Operating Cash Flow | -5.50M |
Capital Expenditures | n/a |
Free Cash Flow | -5.50M |
FCF Per Share | -$0.48 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
HILS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -61.49% |
FCF Yield | -79.53% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -81.40% |
Shareholder Yield | -81.40% |
Analyst Forecast
The average price target for HILS is $6.12, which is 920.00% higher than the current price. The consensus rating is "Buy".
Price Target | $6.12 |
Price Target Difference | 920.00% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |